A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors

A critical requirement in neuroendocrine tumor (NET) management is a blood biomarker test that is sensitive, specific and reproducible. We evaluated a PCR-based 51-transcript signature to detect tumors, compared it with chromogranin A (CgA) and examined the confounding effect of proton pump inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Modlin, Irvin M, Aslanian, Harry, Bodei, Lisa, Drozdov, Ignat, Kidd, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473957/
https://www.ncbi.nlm.nih.gov/pubmed/25316294
http://dx.doi.org/10.1530/EC-14-0100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473957/
https://www.ncbi.nlm.nih.gov/pubmed/25316294
http://dx.doi.org/10.1530/EC-14-0100

Ejemplares similares